USPTO serial 86953893
SOLVENT-LESS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- STRUCK, ROBERT J
- Law office
- TMEG LAW OFFICE 109 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with SOLVENT-LESS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Alcohol for medicinal purposes; Aloe vera preparations for pharmaceutical purposes; Amino acids for medical purposes; Amino acids for veterinary purposes; Antioxidant enriched coffee for medical purposes; Appetite suppressant pills; Bacterial preparations for medical and veterinary use; Bacteriological preparations for medical and veterinary use; Balms for pharmaceutical purposes; Candy, medicated; Cartridges sold pre-filled with gases and gas mixtures for medical use; Chemical preparations for pharmaceutical or medical purposes, namely, for Cancer, Anorexia, AIDS, Chronic pain, Cachexia, Persistent muscle spasms, Seizures, Epilepsy, Severe nausea, Glaucoma, Arthritis, Migraines, Any other chronic or persistent medical symptom that substantially limits the ability of the person to conduct one or more major life activities (as defined by the Americans with Disabilities Act of 1990) or, if not alleviated, may cause serious harm to the patient's safety or physical or mental health.; Dietary pet supplements in the form of pet treats; Dietary supplemental drinks in the nature of vitamin and mineral beverages; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Edible fish oils for medical purposes; Ethers for pharmaceutical purposes; Feeding stimulants for animals; Flower essences for medical purposes for the treatment of Cancer, Anorexia, AIDS, Chronic pain, Cachexia, Persistent muscle spasms, Seizures, Epilepsy, Severe nausea, Glaucoma, Arthritis, Migraines, Any other chronic or persistent medical symptom that substantially limits the ability of the person to conduct one or more major life activities (as defined by the Americans with Disabilities Act of 1990) or, if not alleviated, may cause serious harm to the patient's safety or physical or mental health.; Gels for use as personal lubricant; Glycerine for medical purposes; Greases for medical purposes; Greases for veterinary purposes; Guaiacol for pharmaceutical purposes; Gummy vitamins; Hemorrhoid preparations; Hemorrhoidal ointments; Homeopathic supplements; Infant formula; Local anaesthetics; Malt for pharmaceutical purposes; Medical lubricant, namely, vaginal lubricants; Medical preparations for the treatment of Cancer, Anorexia, AIDS, Chronic pain, Cachexia, Persistent muscle spasms, Seizures, Epilepsy, Severe nausea, Glaucoma, Arthritis, Migraines, Any other chronic or persistent medical symptom that substantially limits the ability of the person to conduct one or more major life activities (as defined by the Americans with Disabilities Act of 1990) or, if not alleviated, may cause serious harm to the patient's safety or physical or mental health.; Medicated animal feed; Medicated balms for treatment of Cancer, Anorexia, AIDS, Chronic pain, Cachexia, Persistent muscle spasms, Seizures, Epilepsy, Severe nausea, Glaucoma, Arthritis, Migraines, Any other chronic or persistent medical symptom that substantially limits the ability of the person to conduct one or more major life activities (as defined by the Americans with Disabilities Act of 1990) or, if not alleviated, may cause serious harm to the patient's safety or physical or mental health.; Medicated cosmetics; Medicated gum for Cancer, Anorexia, AIDS, Chronic pain, Cachexia, Persistent muscle spasms, Seizures, Epilepsy, Severe nausea, Glaucoma, Arthritis, Migraines, Any other chronic or persistent medical symptom that substantially limits the ability of the person to conduct one or more major life activities (as defined by the Americans with Disabilities Act of 1990) or, if not alleviated, may cause serious harm to the patient's safety or physical or mental health.; Medicated hair care preparations; Medicated lip balm; Medicated lotions for Skin; Medicated make-up; Medicated pre-moistened tissues; Medicated pre-moistened towelettes; Medicated pre-moistened wipes; Medicated serums for treatment of Cancer, Anorexia, AIDS, Chronic pain, Cachexia, Persistent muscle spasms, Seizures, Epilepsy, Severe nausea, Glaucoma, Arthritis, Migraines, Any other chronic or persistent medical symptom that substantially limits the ability of the person to conduct one or more major life activities (as defined by the Americans with Disabilities Act of 1990) or, if not alleviated, may cause serious harm to the patient's safety or physical or mental health.; Medicated shampoo; Medicated sun screen; Medicated sunscreen; Medicated supplements for foodstuffs for animals; Medicated throat sprays; Medicated Skin moisturizers; Medicinal oils; Melissa water for pharmaceutical purposes; Mint for pharmaceutical purposes; Nutritionally fortified beverages for medical purposes; Nutritionally fortified water for medical purposes; Pharmaceutical preparations for treating sunburn; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for treating respiratory diseases; Preparation for the relief of pain; Preparations for the treatment of burns; Royal jelly dietary supplements; Royal jelly for pharmaceutical purposes; Saline solution for medical purposes; Sedatives; Sports cream for relief of pain; Stick liquorice for pharmaceutical purposes; Sugar for medical purposes; Therapeutic medicated bath preparations; Therapeutic pharmaceutical for the treatment of Cancer, Anorexia, AIDS, Chronic pain, Cachexia, Persistent muscle spasms, Seizures, Epilepsy, Severe nausea, Glaucoma, Arthritis, Migraines, Any other chronic or persistent medical symptom that substantially limits the ability of the person to conduct one or more major life activities (as defined by the Americans with Disabilities Act of 1990) or, if not alleviated, may cause serious harm to the patient's safety or physical or mental health.; Tranquillizers; Transdermal patches featuring Chemicals for the treatment of ; Cancer, Anorexia, AIDS, Chronic pain, Cachexia, Persistent muscle spasms, Seizures, Epilepsy, Severe nausea, Glaucoma, Arthritis, Migraines, Any other chronic or persistent medical symptom that substantially limits the ability of the person to conduct one or more major life activities (as defined by the Americans with Disabilities Act of 1990) or, if not alleviated, may cause serious harm to the patient's safety or physical or mental health.; Vitamin enriched water for medical purposes; Vitamin fortified beverages for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 3, 2017 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 3, 2017 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 8, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 8, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 8, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 5, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 30, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 29, 2016 | NWAP | NEW APPLICATION ENTERED | — |